Sepah Health Performance After Rise Exceeds 5%, Mid-Year Gross Profit Reaches CNY 1.76 Billion, Gross Margin Rate at 14.4%

Sepah Health (00314) performance after rise exceeds 5%, as of the announcement date, the stock price has risen by 4.66%, currently reported at HK$6.06, with a trading volume of HK$1988.752 million.

On August 18, Sepah Health announced its mid-year performance results for the six months ended June 30, 2025. The company achieved total revenue of CNY 12.24 billion and gross profit of CNY 1.76 billion, with a gross margin rate of 14.4%. Normalized net loss was CNY 1199.6 million, or CNY 0.12 per share.

The announcement stated that in the first half of 2025, the company has made significant progress in implementing its strategic transformation and upgrading plan. Based on the strategic planning established in the fourth quarter of 2024, the company is committed to upgrading into a commercial medical payment and service network, leveraging its commercial medical insurance agency business development, focusing on providing employee healthcare protection and health management services for corporate employees, while continuously integrating national medical service networks and pharmaceutical services resources. Through this efficient integration, Sepah Health aims to provide professionalized healthcare protection plans and high-quality healthcare services to corporate employees and their families, creating a one-stop-shop closed-loop service.